Showing 1 to 1 of 1 results
forbes.com
🌐 85% Global Worthiness


PBMs: The Primary Driver of High Drug Prices
The FTC and DOJ listening sessions revealed that Pharmacy Benefit Managers (PBMs), not pharmaceutical companies, are the primary cause of high drug prices due to their anti-competitive practices; the three largest PBMs control 80% of prescriptions, favoring higher-priced drugs and limiting access to...
PBMs: The Primary Driver of High Drug Prices
The FTC and DOJ listening sessions revealed that Pharmacy Benefit Managers (PBMs), not pharmaceutical companies, are the primary cause of high drug prices due to their anti-competitive practices; the three largest PBMs control 80% of prescriptions, favoring higher-priced drugs and limiting access to...
Progress
56% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results